ANI Pharmaceuticals
ANIP
#4819
Rank
$1.83 B
Marketcap
$81.77
Share price
-1.17%
Change (1 day)
43.53%
Change (1 year)

ANI Pharmaceuticals (ANIP) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.90 Billion USD

According to ANI Pharmaceuticals's latest financial reports the company's total liabilities are $0.90 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ANI Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.85 B91.39%
2023-12-31$0.44 B6%
2022-12-31$0.42 B2.1%
2021-12-31$0.41 B55.51%
2020-12-31$0.26 B8.81%
2019-12-31$0.24 B4.57%
2018-12-31$0.23 B-1.7%
2017-12-31$0.23 B54.93%
2016-12-31$0.15 B22.39%
2015-12-31$0.12 B4.52%
2014-12-31$0.11 B3285.33%
2013-12-31$3.53 M-66.6%
2012-12-31$10.59 M-56.87%
2011-12-31$24.56 M-4.12%
2010-12-31$25.61 M24.33%
2009-12-31$20.6 M434.82%
2008-12-31$3.85 M154.18%
2007-12-31$1.51 M-64.74%
2006-12-31$4.29 M56.03%
2005-12-31$2.75 M44.52%
2004-12-31$1.9 M116.38%
2003-12-31$0.88 M-29.85%
2002-12-31$1.25 M35.4%
2001-12-31$0.92 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Jazz Pharmaceuticals
JAZZ
$7.39 B 719.81%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
$11.68 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$32.60 B 3,513.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
$115.63 B 12,715.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
$0.74 B-17.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$50.07 M-94.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
$57.95 B 6,323.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$62.53 B 6,830.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
$9.72 B 977.92%๐Ÿ‡ฌ๐Ÿ‡ง UK